Singapore markets closed

Verrica Pharmaceuticals Inc. (VRCA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.42-0.14 (-1.64%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
8,913
5,124
9,032
12,000
0
-
Cost of revenue
1,816
746
725
0
-
-
Gross profit
7,097
4,378
8,307
12,000
-
-
Operating expenses
Research development
22,504
20,295
12,198
15,929
15,673
-
Selling general and administrative
59,325
47,305
17,405
26,979
24,508
-
Total operating expenses
81,829
67,600
29,603
42,908
40,181
-
Operating income or loss
-74,732
-63,222
-21,296
-30,908
-40,181
-
Interest expense
6,281
3,962
2,172
4,295
3,034
-
Total other income/expenses net
-
-2,551
-1,495
-
-1
-4
Income before tax
-80,737
-66,995
-24,487
-35,080
-42,694
-
Income from continuing operations
-80,737
-66,995
-24,487
-35,080
-42,694
-
Net income
-80,737
-66,995
-24,487
-35,080
-42,694
-
Net income available to common shareholders
-80,737
-66,995
-24,487
-35,080
-42,694
-
Basic EPS
-1.08
-
-0.72
-1.30
-1.71
-1.13
Diluted EPS
-1.08
-
-0.72
-1.30
-1.71
-1.13
Basic average shares
44,054
-
34,163
27,044
24,996
24,898
Diluted average shares
44,054
-
34,163
27,044
24,996
24,898